Amber Yasmeen

2.6k total citations
75 papers, 1.8k citations indexed

About

Amber Yasmeen is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Amber Yasmeen has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 25 papers in Molecular Biology and 21 papers in Epidemiology. Recurrent topics in Amber Yasmeen's work include Ovarian cancer diagnosis and treatment (21 papers), Cervical Cancer and HPV Research (19 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Amber Yasmeen is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Cervical Cancer and HPV Research (19 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Amber Yasmeen collaborates with scholars based in Canada, Qatar and Syria. Amber Yasmeen's co-authors include Walter H. Gotlieb, Ala‐Eddin Al Moustafa, Marie‐Claude Beauchamp, Nizar Akil, Michaël Pollak, Lina Ghabreau, Ido Laskov, Tarek A. Bismar, Andrew D. Darnel and Amal Kassab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Amber Yasmeen

75 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amber Yasmeen Canada 26 841 755 473 284 275 75 1.8k
Ying‐Cheng Chiang Taiwan 23 552 0.7× 529 0.7× 166 0.4× 222 0.8× 195 0.7× 85 1.8k
Xiaoyan Xin China 25 426 0.5× 998 1.3× 170 0.4× 365 1.3× 139 0.5× 115 1.9k
Danhui Weng China 22 492 0.6× 926 1.2× 97 0.2× 471 1.7× 68 0.2× 41 1.5k
Ling Xue China 26 604 0.7× 797 1.1× 308 0.7× 273 1.0× 344 1.3× 79 2.0k
Huirong Shi China 23 421 0.5× 1.1k 1.4× 99 0.2× 556 2.0× 81 0.3× 91 1.6k
Qian Mei China 29 792 0.9× 1.6k 2.1× 131 0.3× 888 3.1× 183 0.7× 68 3.0k
Jianping Zheng China 20 288 0.3× 727 1.0× 65 0.1× 403 1.4× 130 0.5× 37 1.4k
Wiesława Niklińska Poland 23 393 0.5× 577 0.8× 87 0.2× 271 1.0× 137 0.5× 77 1.3k
Weihong Zhao China 19 214 0.3× 692 0.9× 176 0.4× 389 1.4× 106 0.4× 68 1.1k

Countries citing papers authored by Amber Yasmeen

Since Specialization
Citations

This map shows the geographic impact of Amber Yasmeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Yasmeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Yasmeen more than expected).

Fields of papers citing papers by Amber Yasmeen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber Yasmeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Yasmeen. The network helps show where Amber Yasmeen may publish in the future.

Co-authorship network of co-authors of Amber Yasmeen

This figure shows the co-authorship network connecting the top 25 collaborators of Amber Yasmeen. A scholar is included among the top collaborators of Amber Yasmeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber Yasmeen. Amber Yasmeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Gabriel, Emad Matanes, Amber Yasmeen, et al.. (2024). GD2 and GD3 gangliosides as prognostic biomarkers in high grade serous ovarian cancer. Journal of Gynecology Obstetrics and Human Reproduction. 54(1). 102860–102860. 1 indexed citations
2.
Brezinov, Yoav, et al.. (2024). Ascites and Serum Interleukin-10 Levels as a Prognostic Tool for Ovarian Cancer Outcomes. Cancers. 16(16). 2840–2840. 2 indexed citations
3.
Galán, Alba, Emad Matanes, Fouad Brahimi, et al.. (2023). GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer. Frontiers in Oncology. 13. 1134763–1134763. 11 indexed citations
4.
Matanes, Emad, Amber Yasmeen, Oded Raban, et al.. (2021). Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity. Journal of Obstetrics and Gynaecology Canada. 43(10). 1136–1144.e1. 12 indexed citations
5.
Kessous, Roy, Michel D. Wissing, Ido Laskov, et al.. (2020). Multiple lines of chemotherapy for patients with high‐grade ovarian cancer: Predictors for response and effect on survival. International Journal of Cancer. 148(9). 2304–2312. 6 indexed citations
6.
Kessous, Roy, Kathleen Klein, Liron Kogan, et al.. (2019). Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy. Molecular Cancer Research. 17(12). 2422–2431. 2 indexed citations
7.
Page, Cécile Le, Kurosh Rahimi, Manuel Rodrigues, et al.. (2019). Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis. Gynecologic Oncology. 156(2). 377–386. 22 indexed citations
8.
Kogan, Liron, Jeremie Abitbol, Ido Laskov, et al.. (2018). Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors. Gynecologic Oncology Reports. 24. 43–47. 6 indexed citations
9.
Kessous, Roy, Kathleen Klein, Patricia N. Tonin, et al.. (2018). Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer. Gynecologic Oncology. 148(3). 553–558. 16 indexed citations
10.
Kessous, Roy, Ido Laskov, Jeremie Abitbol, et al.. (2016). Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer. Gynecologic Oncology. 144(3). 474–479. 25 indexed citations
11.
Guerrouahen, Bella S., Jennifer Pasquier, Mahtab Maleki, et al.. (2014). Akt-Activated Endothelium Constitutes the Niche for Residual Disease and Resistance to Bevacizumab in Ovarian Cancer. Molecular Cancer Therapeutics. 13(12). 3123–3136. 30 indexed citations
12.
Yasmeen, Amber, et al.. (2013). Significant toxic role for single-walled carbon nanotubes during normal embryogenesis. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 945–950. 36 indexed citations
13.
Moustafa, Ala‐Eddin Al, Amber Yasmeen, Lina Ghabreau, & Nizar Akil. (2012). Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?. Human Vaccines & Immunotherapeutics. 8(12). 1867–1868. 5 indexed citations
14.
Alazzam, Anas, Ion Stiharu, Amal Kassab, et al.. (2010). Identification of deregulated genes by single wall carbon-nanotubes in human normal bronchial epithelial cells. Nanomedicine Nanotechnology Biology and Medicine. 6(4). 563–569. 29 indexed citations
15.
Kandouz, Mustapha, Amal Alachkar, Li Zhang, et al.. (2009). Teucrium polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the E-cadherin/catenin complex. Journal of Ethnopharmacology. 129(3). 410–415. 49 indexed citations
16.
Moustafa, Ala‐Eddin Al, Amal Kassab, Andrew D. Darnel, & Amber Yasmeen. (2008). High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis. Current Pharmaceutical Design. 14(22). 2159–2172. 28 indexed citations
17.
Yasmeen, Amber, Tarek A. Bismar, Hafedh Dekhil, et al.. (2007). ErbB-2 Receptor Cooperates with E6/E7 Oncoproteins of HPV Type 16 in Breast Tumorigenesis. Cell Cycle. 6(23). 2939–2943. 18 indexed citations
18.
Yasmeen, Amber, Abdel Hosein, Qunyan Yu, & Ala‐Eddin Al Moustafa. (2007). Critical role for D‐type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB‐2 cooperation. Cancer Science. 98(7). 973–977. 10 indexed citations
19.
Yasmeen, Amber, Tarek A. Bismar, & Ala‐Eddin Al Moustafa. (2006). Erbb Receptors and Epithelial-Cadherin–Catenin Complex In Human Carcinomas. Future Oncology. 2(6). 765–781. 26 indexed citations
20.
Yasmeen, Amber, Wolfgang E. Berdel, Hubert Serve, & Carsten Müller‐Tidow. (2003). E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics. 3(5). 617–633. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying‐Cheng Chiang Breakdown of academic impact, for papers by Xiaoyan Xin Breakdown of academic impact, for papers by Danhui Weng Breakdown of academic impact, for papers by Ling Xue Breakdown of academic impact, for papers by Huirong Shi Breakdown of academic impact, for papers by Qian Mei Breakdown of academic impact, for papers by Jianping Zheng Breakdown of academic impact, for papers by Wiesława Niklińska Breakdown of academic impact, for papers by Weihong Zhao
Rankless by CCL
2026